| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Ebola virus infection in host 0.7133481916736375 3.181788630784318 0.00146368597293 0.5901802083459554 0.2166807274572664 43 P05556,P01889,P78536,P05198,O15118,Q08431,P61916,O00459,P04439,P42566,P10321,P06756 12 |
| Degradation pathway of sphingolipids including diseases 0.9742874094249896 2.5210011661726743 0.0117021464254252 0.9992296253953716 0.3327372742403233 6 P17900,P06865,P16278,P06280 4 |
| Allograft rejection 0.8665677552406928 2.4828075969582692 0.0130351472645127 0.9996613684386476 0.3327372742403233 10 P08183,P01889,P04439 3 |
| 7oxoc and 7betahc pathways 0.9064104389619764 2.438413252658931 0.0147518988579453 0.999882706383998 0.3327372742403233 8 P34913,P61916,O15118 3 |
| Pi3kakt signaling pathway 0.5938459946739044 2.4178578082572746 0.0156121762434562 0.9999310973427936 0.3359254451604929 44 Q16543,P62993,Q9Y6K9,P05556,Q9UBI6,P08238,P63151,P23588,P63000,Q02750,P07900,P11047,P06730,O00459,P06756,Q8N122,P28482,P07942,Q15382,P30154,P29317 21 |
| Glycosaminoglycan degradation 0.9762117157300012 2.408996536850783 0.0159964497695472 0.9999456788200624 0.3359254451604929 5 P15586,P54802,P16278,P06865 4 |
| Alzheimers disease 0.508720124816894 2.380735528549487 0.0172781117023785 0.9999754385942832 0.3435958382206551 86 P19525,P28074,P67870,P05067,P04350,P78536,Q07954,P60900,P49768,P49721,Q92542,Q02750,P28070,Q99436,Q9BUF5,O43242,P28072,O00459,P05198,P25788,P07437,Q13885,Q13564 23 |
| Primary focal segmental glomerulosclerosis fsgs 0.7112855306843617 2.376239630373909 0.0174901001393108 0.9999784625911676 0.3435958382206551 21 P05556,Q14108,P19022,Q14517,P11047,P06756 6 |
| Proteasome degradation 0.5885324494343468 2.2963699531280817 0.0216547374586641 0.99999837924589 0.3663624128913313 42 P51665,Q15008,P01889,Q99436,P28074,Q13200,P28070,O43242,P25788,O75832,P25786,P28072,P46934,P60900,P49721,P04439,P10321,P55036 18 |
| Splicing factor nova regulated synaptic proteins 0.7071033645365336 2.246612650502344 0.0246647929861159 0.999999751843338 0.3663624128913313 18 Q06481,Q92859 2 |
| Complement system in neuronal development and plasticity 0.7329715682651942 2.1999868318992446 0.0278078293065557 0.999999965243132 0.3803233243472542 14 Q08431,Q5KU26 2 |
| Alzheimers disease and mirna effects 0.4856615909623183 2.1787301854635976 0.0293517179709703 0.9999999867964372 0.3803233243472542 88 P19525,P28074,P67870,P05067,P04350,P78536,Q07954,P60900,P49768,P49721,Q92542,Q02750,P28070,Q99436,Q9BUF5,O43242,P28072,O00459,P05198,P25788,P07437,Q13885,Q13564 23 |
| Familial hyperlipidemia type 4 0.964755636245445 2.157295231188232 0.03098266834748 0.999999995258554 0.3875834423987085 4 P01130 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8754056745267107 2.1524312671873664 0.0313634032922534 0.99999999626774 0.3875834423987085 6 Q16850,Q9UBM7,Q15392 3 |
| Statin inhibition of cholesterol production 0.8537484540705418 2.1365090555090256 0.0326379436624977 0.9999999983260957 0.3897354449110022 7 P01130,Q07954 2 |
| Sphingolipid metabolism in senescence 0.727947708947489 2.109099145680175 0.0349360245967818 0.9999999996067512 0.3940007218414836 13 Q13510,P16278 2 |
| Folate metabolism 0.7065022907593571 2.074214741307633 0.0380593717715587 0.9999999999453872 0.4214210437978046 14 P01130 1 |
| Ferroptosis 0.6233876764378944 2.0562276173151415 0.0397605814454826 0.9999999999814162 0.4248104228122622 26 P02786,P08195,P02792,Q96QD8 4 |
| Copper homeostasis 0.8471445486214253 2.044230080670555 0.0409308228338076 0.9999999999911569 0.4297736397549805 6 P05067 1 |
| Selenium micronutrient network 0.723601605262156 2.0270396995705378 0.0426583528323991 0.9999999999970504 0.4403209639818828 12 P01130 1 |
| Metapathway biotransformation phase i and ii 0.6330002772692136 1.9820208858166637 0.0474769031151325 0.9999999999998634 0.475121933011137 22 P34913,Q7LGA3,Q86UY6,Q16850 4 |
| Development of ureteric collection system 0.8592127020751724 1.972908261371341 0.0485060152247951 0.9999999999999292 0.475121933011137 5 O94813,Q9Y6N7 2 |
| Oxysterols derived from cholesterol 0.8282260463848033 1.971111662219495 0.0487111050772708 0.999999999999938 0.475121933011137 6 P34913 1 |
| Vitamin d receptor pathway 0.702844102403821 1.9318204466323012 0.0533816715011981 0.9999999999999968 0.475121933011137 12 P08183,P48960 2 |
| Head and neck squamous cell carcinoma 0.6455131840012415 1.9281895859839573 0.0538315490603751 0.9999999999999976 0.475121933011137 18 Q8N122,Q14517,P06730,O00459,Q04721,P62942 6 |
| Arrhythmogenic right ventricular cardiomyopathy 0.6410564973450184 1.9046896643240752 0.0568204233183122 0.9999999999999996 0.4943376828693168 18 P05556,Q14126,P19022,Q02487,P06756 5 |
| Proximal tubule transport 0.6996965522396792 1.8621379162997125 0.062583652712201 1.0 0.5257488445154956 11 P08183,P08195 2 |
| Small cell lung cancer 0.6323481632016371 1.8585953664478836 0.0630845143836131 1.0 0.5257488445154956 18 P05556,P07942,P11047,O00459,P06756 5 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.5141229358479077 1.8423769195080644 0.0654200354678378 1.0 0.5257488445154956 47 P05556,P23588,Q8N122,Q02750,P07942,P07900,P62993,P11047,P06730,Q9Y6K9,Q9Y376,O00459,Q15382,P29317,P08238,Q96B36,P06756,P11166 18 |
| Familial hyperlipidemia type 2 0.9809863339275112 1.8272488159277895 0.0676623671685687 1.0 0.5257488445154956 2 P01130 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.725616593723863 1.8013115816049756 0.0716537834068737 1.0 0.5257488445154956 9 P28482,Q02750,P07900,Q16543,P06400,O00170 6 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.7184049865094239 1.7704618402357504 0.0766502358766025 1.0 0.5403136205062528 9 P05556,Q8N122,Q13418,Q15118,P06730,Q96B36 6 |
| Fluoropyrimidine activity 0.6562621683991167 1.7701380855622602 0.0767041403638479 1.0 0.5403136205062528 13 Q92820 1 |
| Integrinmediated cell adhesion 0.5680045883168685 1.757401228971053 0.078849444000721 1.0 0.5403136205062528 27 P05556,P28482,P63000,Q02750,Q13418,P62993,P46108,O00459,Q13177,P06756 10 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.7940614488484068 1.722007496290792 0.08506816055478 1.0 0.5403136205062528 5 P61201,P06753,P22466 3 |
| Familial hyperlipidemia type 3 0.973551263001486 1.7055608181273278 0.0880898797256493 1.0 0.5403136205062528 3 P01130,Q07954 2 |
| Familial hyperlipidemia type 5 0.97316958917999 1.7041913495305092 0.088345344779251 1.0 0.5403136205062528 3 P01130 1 |
| Familial hyperlipidemia type 1 0.97316958917999 1.7041913495305092 0.088345344779251 1.0 0.5403136205062528 3 P01130 1 |
| P53 transcriptional gene network 0.6604911665574298 1.6830572289394756 0.0923640132625678 1.0 0.544266828605518 11 P04066 1 |
| Irinotecan pathway 0.9423648247177672 1.674408386774169 0.0940503656610038 1.0 0.544266828605518 2 O15118 1 |
| Genes controlling nephrogenesis 0.7135805063180252 1.6611603263414785 0.0966812512215262 1.0 0.544266828605518 8 P05556,Q13418,O94813,P11047,Q04721 5 |
| Notch signaling 0.7131466974132968 1.6593421289667367 0.097046870531587 1.0 0.544266828605518 8 P49768,P78536,Q92542 3 |
| Inflammatory response pathway 0.9385026737967924 1.6590910321902188 0.0970974500768102 1.0 0.544266828605518 2 P07942 1 |
| Monoamine transport 0.9292929292929304 1.6225497587189155 0.1046856879981241 1.0 0.544266828605518 2 O15127 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.7683615819208968 1.621732387048756 0.1048606610153317 1.0 0.544266828605518 5 O00170,Q07812,P07900,Q15185 4 |
| Imatinib and chronic myeloid leukemia 0.8188488158268921 1.614965404237307 0.1063181870179996 1.0 0.544266828605518 4 P08183 1 |
| Hippomerlin signaling dysregulation 0.563383529917199 1.609322132707727 0.1075459219583405 1.0 0.544266828605518 23 P05556,P19022,P29317,P10644,P06756 5 |
| Tcell receptor tcr signaling pathway 0.5779258201098986 1.6050658988529003 0.1084793029948201 1.0 0.544266828605518 19 P28482,Q02750,Q9UJU6,Q06124,P62993,Q16512,P46108,Q9Y6K9,P36507,O00459,Q04206,P27361,P08670 13 |
| Alpha 6 beta 4 signaling pathway 0.6430746602616081 1.6025587506104473 0.1090321068799231 1.0 0.544266828605518 11 P07942,O00459,P11047 3 |
| Vitamin b12 metabolism 0.6970025006279451 1.59149620315782 0.111497949227767 1.0 0.5520508217862611 8 P01130 1 |
| Malignant pleural mesothelioma 0.452634699500926 1.5859984489291774 0.1127396614115703 1.0 0.5536972080616639 73 P05556,Q8N122,P19022,Q02487,P11166,P09429,P07942,P67870,P11047,Q14574,P29317,Q96B36,Q08722,P08195,P06756 15 |
| Nuclear receptors metapathway 0.4745575179396544 1.5697803795291236 0.1164662137030516 1.0 0.5541244073840504 54 P08183,Q08431,P02792,P27105,O00170,P29317,Q9H2J7,Q15043 8 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.6319625697245168 1.5509239577109315 0.1209199082764174 1.0 0.5664632626179862 11 Q8N122,P54619,Q05086,O00459,Q15382 5 |
| Translation factors 0.5003526117963328 1.51124590108186 0.1307258116453475 1.0 0.5985866112181705 37 P19525,Q14240,O60841,O75821,Q13347,P60842,Q9NR50,P55010,O00303,O75153,P24534,P23588,P62495,Q04637,P63241,P06730,P26641,P55884,P05198,P49770,O15372,P20042,O75822,Q15056,P29692,Q13144 26 |
| Metabolic pathway of ldl hdl and tg including diseases 0.91483170285774 1.4942458617041958 0.1351113696325585 1.0 0.5986635384743854 3 P01130 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.6928691144588782 1.4922606137304797 0.1356308377008619 1.0 0.5986635384743854 7 Q8N122,Q15118,O00459 3 |
| Inclusion body myositis 0.907875185735513 1.469166128092526 0.1417877350663849 1.0 0.5986635384743854 3 P05067,Q92542 2 |
| Glucocorticoid receptor pathway 0.6673359761605431 1.4659890014036043 0.142651283243377 1.0 0.5986635384743854 8 Q08431 1 |
| Tgfbeta signaling pathway 0.5067756009187703 1.45656014886673 0.1452378348640177 1.0 0.5986635384743854 32 P05556,P63000,Q02750,Q15118,P06493,P62993,P05067,O00459,O14964,Q13177,Q96PU5,Q96J02,Q92905 13 |
| Spinal cord injury 0.5429380324100024 1.4446890619568389 0.1485452436241636 1.0 0.5986635384743854 21 P63000,O94813,P17931,P06493,Q08722,P62942 6 |
| Nephrotic syndrome 0.5884030153760655 1.438663977802391 0.1502457500961469 1.0 0.5986635384743854 13 Q14108,O75844 2 |
| Vitamin d metabolism 0.8986016070487246 1.4357346376860936 0.1510778650222417 1.0 0.5986635384743854 3 P04062 1 |
| Complement system 0.5973560268828976 1.4337423536880771 0.1516458009131169 1.0 0.5986635384743854 12 P07942 1 |
| Network map of sarscov2 signaling pathway 0.5048159667249013 1.4134450668584209 0.1575249025474283 1.0 0.6086826642737531 30 Q8N122,Q08380,P60520,P06730,Q9Y6K9,Q15382,Q96B36,Q96J02 8 |
| Regulation of actin cytoskeleton 0.4799433443653297 1.4112196011765696 0.1581798722701273 1.0 0.6086826642737531 39 P15311,P07737,Q16512,P23528,Q96F07,P35580,Q9UBI6,P12814,Q9NSV4,Q02750,P63000,Q9Y6W5,P36507,O00459,Q13177,P28482,Q9UQB8,P46108,P46940,P26038,P27361 21 |
| Nanoparticlemediated activation of receptor signaling 0.686573112777274 1.4087228053343914 0.1589171488005365 1.0 0.6086826642737531 6 P05556,Q02750,P62993 3 |
| Orexin receptor pathway 0.5379075459826426 1.39703478695186 0.1624031104526451 1.0 0.6181468391603804 20 P01130,O00459 2 |
| Purine metabolism 0.665605146426848 1.3799729063709318 0.1675949870215349 1.0 0.6261677735957962 7 P00492,P07741 2 |
| Dna damage response only atm dependent 0.5315298054854158 1.3603959113949124 0.1737046716259223 1.0 0.6369657561755947 20 P01130,Q15118,O00459,P09429 4 |
| Nephrogenesis 0.8621509209744502 1.3562717562604538 0.1750127184192502 1.0 0.6369657561755947 2 Q04721 1 |
| Met in type 1 papillary renal cell carcinoma 0.5265863105080616 1.3494926351078675 0.1771787843554442 1.0 0.6369657561755947 21 P28482,P63000,Q02750,P62913,Q06124,P62993,Q16512,P46108,P36507,O00459,Q13177,Q92733,P27361 13 |
| Mapk cascade 0.6978887897710288 1.3442967265062702 0.1788524537044773 1.0 0.6369657561755947 5 Q02750,P28482,P36507,P62993 4 |
| Hippo signaling regulation pathways 0.5371600700462994 1.3086650569258464 0.1906478331561762 1.0 0.652272642652311 17 P19022,P29317 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4859512976231864 1.300255996684887 0.1935132441873208 1.0 0.6583774620674772 31 P01130,Q8WTV0 2 |
| Thyroid hormones production and peripheral downstream signaling effects 0.5281970089144382 1.2909739420951607 0.1967127134193931 1.0 0.66554468040228 18 Q8N122,P62993,Q15382,Q96B36,P06756 5 |
| Focal adhesion 0.4632836290321724 1.2637593299273542 0.2063164228106502 1.0 0.6718038476250511 38 P05556,P28482,P63000,Q02750,Q13418,P07942,P62993,Q16512,P11047,P46108,O00459,Q13177,P06756 13 |
| Hair follicle development cytodifferentiation part 3 of 3 0.6772200770804349 1.2626509170136666 0.2067146607043311 1.0 0.6718038476250511 5 Q02487,P78536 2 |
| Interferon type i signaling pathways 0.5272137282190479 1.254412101826868 0.2096922561108836 1.0 0.6718038476250511 17 P23588,Q8N122,Q53EL6,P06730,O00459 5 |
| Hepatocyte growth factor receptor signaling 0.56022579603788 1.2540754050310463 0.2098145990115312 1.0 0.6718038476250511 12 P05556,P28482,Q02750,Q06124,P46108,P62993,Q16512,P36507,P27361 9 |
| Ras signaling 0.4870276899554418 1.24348608845087 0.213688764212502 1.0 0.6718038476250511 27 P28482,P63000,Q02750,Q9UBI6,Q06124,P62993,Q16512,Q9Y6K9,P36507,O00459,P29317,Q13177,Q04206,P27361,P11233 15 |
| Base excision repair 0.5107773011968286 1.2405902525761534 0.2147571546247539 1.0 0.6718038476250511 20 P09429,P49005,Q9NRF9,P29372,P13051 5 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.5572396188740844 1.2395718623118226 0.2151337934268282 1.0 0.6718038476250511 12 P28482,P63000,Q02750,Q9UIW2,P36507,Q04206,O14786 7 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.5332723661135724 1.2328193594428902 0.217643166846011 1.0 0.6718038476250511 15 Q12959,Q02750,Q15118,P27361,P62993,Q16512,P36507,Q9Y6K9,O95433 9 |
| Bladder cancer 0.606775610653052 1.2075559767689426 0.2272181013652505 1.0 0.6718038476250511 8 P28482,Q02750,P06400,O00459,P42771 5 |
| Kallmann syndrome 0.7098692033293644 1.2008521926044948 0.2298085418148761 1.0 0.6718038476250511 4 P62993,P28482,Q06124 3 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.4340441864271762 1.1986498980886064 0.2306641071904258 1.0 0.6718038476250511 46 Q99523,P19022,P13591,P78536,P10586,P84095,P67809,Q9Y6K9,O00459,P05198 10 |
| Sarscov2 and covid19 pathway 0.707836859364736 1.1931514476756633 0.2328100656545335 1.0 0.6718038476250511 4 Q8WTV0 1 |
| Rac1pak1p38mmp2 pathway 0.5148403556148443 1.1867439771002095 0.2353286227764521 1.0 0.6718038476250511 17 P05556,P28482,P63000,P46108,P62993,P43246,Q9Y6K9,Q16512,Q07812,Q04206,P16949 11 |
| Ketogenesis and ketolysis 0.6274536181534277 1.1695279107655894 0.2421910028069316 1.0 0.6718038476250511 6 O43772 1 |
| Notch signaling pathway 0.5109179440958572 1.1652607054411332 0.2439134797008315 1.0 0.6718038476250511 17 P78536,Q92542,O00459,Q04721,P49768 5 |
| Canonical and noncanonical notch signaling 0.8224367690018013 1.1624071660604005 0.2450701138183051 1.0 0.6718038476250511 3 P49768 1 |
| Sudden infant death syndrome sids susceptibility pathways 0.4682656662734944 1.1576278066279526 0.2470159566575591 1.0 0.6718038476250511 29 P42892,P67809,P10644 3 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.6976813317479136 1.154724185881798 0.2482033919796933 1.0 0.6718038476250511 4 Q02750,P28482,P36507 3 |
| Serotonin receptor 467 and nr3c signaling 0.6976813317479136 1.154724185881798 0.2482033919796933 1.0 0.6718038476250511 4 Q02750,P28482,P36507 3 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.6976813317479105 1.154724185881785 0.2482033919796986 1.0 0.6718038476250511 4 P19022,P28482,P08670 3 |
| Supression of hmgb1 mediated inflammation by thbd 0.6798653983245662 1.0875771876965703 0.2767818060290929 1.0 0.7248543322398626 4 P09429 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.5293552761569168 1.067654435293749 0.2856764190138126 1.0 0.7403274007634548 11 Q13685,P63000,Q7L5N1,P07900,Q9Y6K9 5 |
| Kisspeptinkisspeptin receptor system in the ovary 0.5996757312871382 1.0575125964007204 0.2902777088740991 1.0 0.7451892826581339 6 Q02750,Q15118,P28482,P36507 4 |
| Hijack of ubiquitination by sarscov2 0.6245259909852234 1.0554416168734606 0.2912233978204201 1.0 0.7451892826581339 5 Q8TBC4,Q13564,Q13617 3 |
| Hair follicle development organogenesis part 2 of 3 0.6703348055796288 1.0518335874794331 0.2928759061904689 1.0 0.7462821207949604 4 P13591 1 |
| Sphingolipid pathway 0.5492973346959895 1.0291435420790251 0.303412227836461 1.0 0.7541961091934889 9 Q13510 1 |
| Pathogenic escherichia coli infection 0.4706818261507587 1.0202969052249995 0.3075876706361493 1.0 0.755750514981073 21 P05556,P04350,Q14247,P63104,P15311,Q9BUF5,P07437,Q13885,O15143,P19338 10 |
| Ciliopathies 0.4682048009909573 1.020014641995179 0.3077215166275282 1.0 0.755750514981073 22 O43924,Q10713,Q9ULC3 3 |
| 15q112 copy number variation syndrome 0.6605231866825128 1.0151938929080473 0.3100134111717858 1.0 0.755750514981073 4 Q9BSJ2,Q06787,Q96CW5 3 |
| Tcell activation sarscov2 0.4816125896082365 1.0045418715480472 0.3151174994640611 1.0 0.755750514981073 17 Q8N122,P28482,Q02750,P62993,P36507,P42771,Q15382,Q9Y6K9,Q07812,Q04206 10 |
| Nrf2 pathway 0.4516546052735338 0.99048753593558 0.3219358783736579 1.0 0.758962229936051 26 P02792,Q9H2J7,Q15043,P29317 4 |
| Disruption of postsynaptic signaling by cnv 0.5392188644038127 0.9847700893688248 0.3247370158588065 1.0 0.758962229936051 9 Q14168,Q12959,Q06787 3 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.5695755907460733 0.9836868099574132 0.3252695271154504 1.0 0.758962229936051 7 P28482,Q96KB5,Q02750,P06730,P36507 5 |
| Target of rapamycin tor signaling 0.5031614906585622 0.9768535599732744 0.3286416556362601 1.0 0.7639036957346658 12 Q8N122,P54619,Q96B36,Q15382,P62942 5 |
| Fragile x syndrome 0.4040321285509856 0.951141800953369 0.3415323975416311 1.0 0.7712337146989036 46 Q8N122,P09496,Q15118,Q06787,Q14118,P62993,P06730,P05067,Q96B36,P10644 10 |
| Endochondral ossification 0.5589850919691073 0.9404652662142028 0.3469789580097107 1.0 0.7712337146989036 7 Q96QD8 1 |
| Endochondral ossification with skeletal dysplasias 0.5589850919691073 0.9404652662142028 0.3469789580097107 1.0 0.7712337146989036 7 Q96QD8 1 |
| Erbb signaling pathway 0.4645202824911006 0.9344411143607418 0.3500763978750023 1.0 0.7712337146989036 18 P28482,Q02750,P46108,P62993,Q16512,P36507,O00459,Q13177,P27361 9 |
| Cannabinoid receptor signaling 0.5684025737477939 0.9325704298867716 0.3510418068183412 1.0 0.7712337146989036 6 P10644,Q8NCG7 2 |
| Ebsteinbarr virus lmp1 signaling 0.5667168154991662 0.9258881134475028 0.3545041292033435 1.0 0.7712337146989036 6 P28482,Q9Y6K9,P07900 3 |
| Melanoma 0.4742457657080259 0.922916118323355 0.3560509201753075 1.0 0.7712337146989036 15 P28482,P63000,Q02750,P06400,P62993,Q16512,P36507,O00459,P42771,Q07812 10 |
| Erk pathway in huntingtons disease 0.7474747474747516 0.912993639821517 0.3612458865965999 1.0 0.7719254208327346 2 P28482 1 |
| Prostaglandin and leukotriene metabolism in senescence 0.7488855869242208 0.9051808858167228 0.3653695663442273 1.0 0.775568715611275 3 P09960,P63096 2 |
| Regulatory circuits of the stat3 signaling pathway 0.5339202644952606 0.897700666046654 0.3693451542848582 1.0 0.775568715611275 8 Q8N122,P16949 2 |
| Il6 signaling pathway 0.485202059376385 0.8901818911946738 0.3733682266290954 1.0 0.7761428397150615 12 P28482,P63000,Q02750,Q06124,P62993,P36507,O00459 7 |
| Joubert syndrome 0.4516923919360553 0.887420243729179 0.3748526884869423 1.0 0.7764805690086661 19 O43924,Q10713,Q15154,P41208 4 |
| Hypertrophy model 0.7346999405822978 0.8657655484873302 0.3866187456042094 1.0 0.7913788658647697 2 P06730 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4377128658755697 0.8651051863685612 0.3869810583598054 1.0 0.7913788658647697 24 Q16850,Q14739,Q9UBM7,Q15392 4 |
| Pilocytic astrocytoma 0.7296494355317934 0.8472768927306348 0.3968408031953316 1.0 0.8060076257328421 2 P62993 1 |
| Hepatitis b infection 0.4316250715051002 0.8436195243819177 0.3988820504290187 1.0 0.8070404276122006 25 P28482,P63104,Q02750,P62993,P27348,Q15904,Q9Y6K9,O00459,Q07812,Q04206 10 |
| Autophagy 0.4904454455108039 0.8260462471101797 0.4087778579584602 1.0 0.8162154606449255 10 Q8N122,Q96B36 2 |
| Praderwilli and angelman syndrome 0.5289140756301813 0.8191449452674268 0.4127037214109199 1.0 0.8197435493450986 7 Q05086,P42771,Q15154 3 |
| Mirna regulation of prostate cancer signaling pathways 0.4877999490766181 0.8142360487136734 0.4155097377684078 1.0 0.8197435493450986 10 Q02750,Q8NCF5,Q9Y6K9,P62993 4 |
| Proteoglycan biosynthesis 0.604192336089423 0.8093213797046204 0.4183303116603927 1.0 0.8218166445199326 4 Q9NX62 1 |
| Glioblastoma signaling pathways 0.4446736405415001 0.7847530139849845 0.4325983934039006 1.0 0.8417010274216468 16 P28482,Q02750,P06400,P62993,P36507,O00459,P42771,P52701 8 |
| Ethanol metabolism production of ros by cyp2e1 0.7094474153297736 0.7744860152106138 0.4386434350896933 1.0 0.846986260843624 2 Q02750 1 |
| Resistin as a regulator of inflammation 0.5226904829126441 0.7542618241064005 0.4506920208047233 1.0 0.8550512170407368 6 P28482,Q9Y6K9,Q04206 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4404768261675537 0.7476013527217096 0.4547006485578513 1.0 0.8573148451137196 15 P55209,O75844 2 |
| Angiotensin ii receptor type 1 pathway 0.6986014556174549 0.7377218145008031 0.4606835131469939 1.0 0.8623524271677969 3 P28482 1 |
| Neovascularisation processes 0.6974739970282328 0.7340804586888845 0.4628997025607408 1.0 0.8623524271677969 3 Q04206,P28482 2 |
| Mapk pathway in congenital thyroid cancer 0.6974739970282327 0.7340804586888837 0.4628997025607413 1.0 0.8623524271677969 3 Q02750,P36507 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4427600292853416 0.715679886858216 0.4741890329019163 1.0 0.8665828037668527 13 O15372,O75821,P20042,O75822,Q13347,P55010,P55884,P05198 8 |
| Egfr tyrosine kinase inhibitor resistance 0.4340600434454111 0.7147221950825798 0.4747807202416674 1.0 0.8665828037668527 15 Q02750,P62993,P06730,O00459,Q07812 5 |
| Il9 signaling pathway 0.4896324302519154 0.7147008122452595 0.4747939357496411 1.0 0.8665828037668527 8 P28482,Q02750,P62993,P36507,O00459 5 |
| Prolactin signaling pathway 0.4168405990436498 0.712640080061791 0.4760685035693281 1.0 0.8665828037668527 22 P05556,P28482,P63104,P63000,Q02750,Q06124,P62993,Q16512,P36507,O00459,Q04206 11 |
| Purine metabolism and related disorders 0.4460667461263057 0.7044199803593472 0.4811712666916623 1.0 0.8669624302225514 12 P30520,Q9BY32,P07741,P22102,P31153,P00491,P00492,Q06203,P31939,P30566,P22234 11 |
| Cellular proteostasis 0.6869795814859763 0.7004681545542407 0.4836349861550191 1.0 0.8688309928271583 3 Q99471 1 |
| Physicochemical features and toxicityassociated pathways 0.4302388022098761 0.695232085410893 0.4869098677678494 1.0 0.8721414984430008 15 P35080,P28482,Q02750,P62993,P07737,P07197 6 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.4592300375541569 0.6884048138030163 0.4911978932788563 1.0 0.8771964815130111 10 P05556,Q16512,Q13177 3 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.4277563709651429 0.6826094834147509 0.4948536399793912 1.0 0.8786176873103477 15 Q8N122,Q96B36,Q15382,P02792 4 |
| Tolllike receptor signaling pathway 0.4299658232864369 0.6542866704448467 0.5129271319716329 1.0 0.8938574619367246 13 P28482,P63000,Q02750,P36507,O00459,Q9Y6K9,Q04206 7 |
| Cholesterol biosynthesis pathway 0.423756825735714 0.6518850732329959 0.5144753149209238 1.0 0.8938574619367246 14 Q16850,Q9UBM7 2 |
| Tolllike receptor signaling related to myd88 0.5581931405593364 0.6500365717507577 0.5156685985632363 1.0 0.8938574619367246 4 P28482,Q9Y6K9 2 |
| Chemokine signaling pathway 0.3998777708639308 0.6324900988411902 0.5270666762545444 1.0 0.9041791713775142 24 P28482,P63000,Q02750,P63096,Q9UBI6,P62993,Q16512,P46108,Q9Y6K9,O00459 10 |
| 16p112 distal deletion syndrome 0.4564263030875589 0.6301118382686454 0.5286214148376938 1.0 0.9042989933599874 9 P62993,Q9H2V7 2 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.4770901126207258 0.6179441766533168 0.5366121370791543 1.0 0.915397175017381 7 Q9UPY5,Q9Y6K9 2 |
| Estrogen signaling pathway 0.4835388620852917 0.6084966668003527 0.542858115994862 1.0 0.9228513822342292 6 Q02750,Q9Y6K9 2 |
| Epo receptor signaling 0.4533882213329201 0.5715968068811118 0.5675951592063544 1.0 0.933956311816447 8 P28482,Q02750,Q15118,P62993,P36507 5 |
| Modulators of tcr signaling and t cell activation 0.4109157477163013 0.5647419748364247 0.5722492794666292 1.0 0.933956311816447 13 Q9Y6K9,O00459,O96000 3 |
| Parkinubiquitin proteasomal system pathway 0.3733303118570584 0.5563179106292658 0.577993545283022 1.0 0.933956311816447 35 Q13200,P54652,O75832,Q9BVA1,Q15008,P04350,Q99460,P68036,Q9BUF5,O43242,Q9UNE7,P55036,P51665,P62333,Q9UNM6,Q0VDF9,P34932,P07437,Q13885,O00231 20 |
| Nonsmall cell lung cancer 0.3952652035236277 0.5537716251417533 0.5797351496508645 1.0 0.9340177411041706 18 P28482,Q02750,Q15118,P62993,O00459,P42771,Q07812,Q9HC35 8 |
| Oxidation by cytochrome p450 0.4674698315558155 0.551352558665447 0.5813920154707457 1.0 0.9342156660202748 6 Q16850 1 |
| Ectoderm differentiation 0.3870836308538016 0.5461840020436773 0.5849394618783288 1.0 0.93744245337869 23 O00560,P26583,P16278 3 |
| Il7 signaling pathway 0.443084319049625 0.5324817160830165 0.5943924019406421 1.0 0.947604640790186 8 Q02750,P28482,P36507,O00459 4 |
| Translation inhibitors in chronically activated pdgfra cells 0.3802297617025063 0.4881036862480989 0.6254764001832265 1.0 0.9762277041996652 19 P23588,Q8N122,Q53EL6,Q15118,P06730,O00459 6 |
| Pancreatic adenocarcinoma pathway 0.3738300192998741 0.4766022926948697 0.6336453505075361 1.0 0.9823564179255578 24 Q13177,P28482,P63000,Q02750,P06400,Q16512,Q9Y6K9,P42771,O00459,Q07812,P11233 11 |
| Endometrial cancer 0.3914453019660919 0.4761964376370367 0.6339344371834881 1.0 0.9823564179255578 13 Q13418,Q02750,P62993,O00459,Q07812 5 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.4408090422367581 0.4609974313491523 0.6448004479823908 1.0 0.9891271355699648 6 Q9UPY5,P09601,Q13155,P48506,P48507 5 |
| Mirna biogenesis 0.4904875148632469 0.4399427191264608 0.6599785946487844 1.0 0.9990835718225328 4 P62826,Q9HAV4,Q9UPY3 3 |
| Transsulfuration pathway 0.42517108003571 0.4334303959929285 0.6647021222385598 1.0 0.9990835718225328 7 Q9NZL9,Q99707,P17174,P23526,P48507,P26358 6 |
| Il1 signaling pathway 0.3802690297352585 0.4270584201120563 0.6693367771815983 1.0 0.9990835718225328 13 P28482,P61088,Q02750,Q06124,P36507,O00459,Q9Y6K9,Q04206 8 |
| Vasopressinregulated water reabsorption 0.3700189832897348 0.4224356411281998 0.6727070676514391 1.0 0.9994172973938285 18 Q96FJ2,O43237,P52565,Q9UJW0,Q13561,Q14203,Q12846,Q13409 8 |
| Influence of laminopathies on wnt signaling 0.4017778452475213 0.4169529858464563 0.6767127962298334 1.0 1.0 9 O75844 1 |
| Pentose phosphate metabolism 0.4391911983348277 0.3992960708037375 0.6896750619446628 1.0 1.0 5 P37837,O95336,P29401,P52209 4 |
| Burn wound healing 0.4057187487337683 0.3984016427518163 0.6903341471888005 1.0 1.0 8 P07737,P09429,P08670 3 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.4207034643189517 0.3972326542203218 0.6911959043440379 1.0 1.0 6 Q02750,P28482,P36507 3 |
| Genes related to primary cilium development based on crispr 0.372243417543492 0.3926580564021956 0.6945720535803477 1.0 1.0 13 Q9Y366,Q10713,Q96J42,Q9ULC3 4 |
| Tnfalpha signaling pathway 0.3599260869389045 0.3833033086355314 0.7014948863239545 1.0 1.0 21 P28482,Q9NR28,P63000,Q6GQQ9,Q13200,P06737,P07900,P62993,Q9Y6K9,Q07812 10 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.4678953626634841 0.3787449843039644 0.7048772449755087 1.0 1.0 4 Q99707,P55263,P23526 3 |
| Cardiac hypertrophic response 0.3736825767540768 0.3758443642450615 0.7070326038453647 1.0 1.0 11 P28482,P63000,Q02750,Q9Y6K9,P36507 5 |
| Gpr40 pathway 0.5796197266785603 0.3740951125658272 0.7083335547602285 1.0 1.0 2 P19174 1 |
| Pdgfrbeta pathway 0.3977337718624546 0.3716127399892754 0.7101812022228879 1.0 1.0 8 P62993,P19525 2 |
| Striated muscle contraction pathway 0.4288753836524481 0.370175924283423 0.7112514140733945 1.0 1.0 5 P06753,O43707,P67936 3 |
| Ciliary landscape 0.3288580609530854 0.363646906982278 0.7161216946998374 1.0 1.0 108 P27105,P06280,P10619,Q86VI3,P16278,Q9H9Q2 6 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.5615076680394678 0.3532014644439377 0.7239374100823679 1.0 1.0 3 Q9Y6K9 1 |
| Il2 signaling pathway 0.3635318843223081 0.337516957698133 0.7357272309529579 1.0 1.0 11 P28482,Q02750,Q06124,P62993,P36507,P27361 6 |
| Tp53 network 0.5528581554363385 0.33408365050967 0.738316436994368 1.0 1.0 3 Q07812 1 |
| Microglia pathogen phagocytosis pathway 0.4136024351425155 0.3293309900530298 0.7419055227072067 1.0 1.0 5 O15143,O00459 2 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3908208440799451 0.3107910185750869 0.7559594979465505 1.0 1.0 6 Q9Y6K9 1 |
| Neural crest differentiation 0.367987531011364 0.300450283504579 0.7638337135468698 1.0 1.0 9 P05556,P19022 2 |
| Nitric oxide metabolism in cystic fibrosis 0.4341638151497272 0.2977257354334839 0.7659124996434032 1.0 1.0 4 O60678 1 |
| Complement and coagulation cascades 0.5407011289364348 0.2864953905396595 0.7744987234021266 1.0 1.0 2 P49257 1 |
| Intraflagellar transport proteins binding to dynein 0.3683917960327758 0.2800010203991655 0.7794767220254366 1.0 1.0 8 Q9BW83,Q96FJ2,O43237,Q9Y6G9,Q13409 5 |
| Neural crest cell migration during development 0.3775224328206288 0.2759461288583101 0.7825894431437674 1.0 1.0 6 Q13177,P63000 2 |
| Serotonin htr1 group and fos pathway 0.3658351510173723 0.2725734341254736 0.7851811354022269 1.0 1.0 8 Q02750,P28482,P36507,P63096 4 |
| Fibrin complement receptor 3 signaling pathway 0.5176607283114181 0.2641910906601526 0.7916326758822032 1.0 1.0 3 Q9Y6K9 1 |
| Canonical nfkb pathway 0.5176607283114181 0.2641910906601526 0.7916326758822032 1.0 1.0 3 Q9Y6K9 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.5176607283114181 0.2641910906601526 0.7916326758822032 1.0 1.0 3 Q9Y6K9 1 |
| Familial partial lipodystrophy fpld 0.3716619254622172 0.2613568442533632 0.7938173339834607 1.0 1.0 6 O75844 1 |
| Nad metabolism 0.5246583481877723 0.2557595879314474 0.7981364803778828 1.0 1.0 2 P43490 1 |
| Pentose phosphate pathway in senescent cells 0.3826940231935864 0.2557037058714223 0.7981796334110443 1.0 1.0 5 P37837,P11413,O95336,P29401 4 |
| Wnt signaling pathway 0.3391899940440701 0.2308061883006285 0.8174653734599899 1.0 1.0 10 P28482,P63000,Q9BTU6,P17252,P49841,P49840,P42345,Q13363,P35222 9 |
| Embryonic stem cell pluripotency pathways 0.3302182350664411 0.2226698788668333 0.8237924459895911 1.0 1.0 11 P28482,Q02750,Q06124,P62993,O00459 5 |
| Exrna mechanism of action and biogenesis 0.490341753343241 0.2190620788600596 0.8266016899989357 1.0 1.0 3 Q9HAV4,Q9UPY3 2 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3446428571428593 0.214782659212564 0.8299367733341572 1.0 1.0 8 Q96JM3,P28482,Q13555,Q15648,P27361,P17252,P42224 7 |
| Il4 signaling pathway 0.3276544565305924 0.2146084292818944 0.830072621444419 1.0 1.0 11 P28482,Q06124,P62993,O00459,Q04206 5 |
| Camkk2 pathway 0.3273394826230014 0.2142707694780825 0.830335911253973 1.0 1.0 12 Q8N122,Q9Y3D6,P28482,O00429,P63000 5 |
| Follicle stimulating hormone fsh signaling pathway 0.3457304373698429 0.2073748324623645 0.8357171361665279 1.0 1.0 7 P28482,P17612,Q15382,P62753,P27361,P17252 6 |
| Progeriaassociated lipodystrophy 0.3348137143256768 0.201753404317581 0.8401095103466407 1.0 1.0 9 O75844 1 |
| Ccl18 signaling pathway 0.3223897031194346 0.1984331660449629 0.8427061705814378 1.0 1.0 11 P19022 1 |
| Hepatitis c and hepatocellular carcinoma 0.3375823853910212 0.1970971721148817 0.8437514963494861 1.0 1.0 8 Q06124,Q14247,P62993,P63000 4 |
| T cell receptor and costimulatory signaling 0.338887235941691 0.1920660668264687 0.8476904547717208 1.0 1.0 7 Q15118,Q08209,P49841,P49840,P19174,P17252 6 |
| Gastrin signaling pathway 0.3204608403384492 0.1908470158025438 0.8486454523168216 1.0 1.0 27 P05556,P28482,P63000,Q02750,P62993,Q16512,P46108,P42771,O00459,Q04206 10 |
| Folatealcohol and cancer pathway hypotheses 0.4812834224599071 0.188745043578462 0.8502926463622729 1.0 1.0 2 Q99707 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.3455248290217168 0.1846167820608353 0.8535296220322879 1.0 1.0 5 Q9NT62,O95352,Q99570,O75143 4 |
| Dual hijack model of vif in hiv infection 0.4528974739970299 0.1702946641240885 0.8647784073842786 1.0 1.0 3 Q15369,Q93034 2 |
| Microtubule cytoskeleton regulation 0.3152488393228187 0.1672027788304503 0.8672104980096305 1.0 1.0 18 Q15691,P63000,P06493,Q16512,P16949 5 |
| Acute viral myocarditis 0.3128398620162732 0.1572606144275973 0.8750394591094603 1.0 1.0 18 P78310,Q14118,Q07812,Q13418 4 |
| Sulfation biotransformation reaction 0.438930163447253 0.1558450716476221 0.8761551426045802 1.0 1.0 3 O43252,P00390 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.3448275862068916 0.1515759468644638 0.8795214057930667 1.0 1.0 4 P28482,Q13464,P49841 3 |
| Hippoyap signaling pathway 0.3403686087990417 0.146920879441652 0.8831944713489632 1.0 1.0 4 P27348,O95819,Q13188 3 |
| Overview of interferonsmediated signaling pathway 0.440285204991102 0.1459371380340228 0.8839710135166972 1.0 1.0 2 P42224 1 |
| Relationship between inflammation cox2 and egfr 0.4276374442793481 0.1455636124272489 0.8842658950273692 1.0 1.0 3 P28482,P27361 2 |
| Rala downstream regulated genes 0.3132017363737629 0.1436269363312786 0.8857950690706915 1.0 1.0 6 P11233 1 |
| Type 2 papillary renal cell carcinoma 0.3064561595683798 0.1320549020253655 0.8949408664035368 1.0 1.0 9 Q92733,P11166 2 |
| Il17 signaling pathway 0.3065290613127001 0.1298269618348474 0.8967033309807828 1.0 1.0 7 P28482,Q9Y6K9,Q04206 3 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.3988112927191698 0.1245650989934575 0.9008678601045867 1.0 1.0 3 Q07812,Q07820 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3010633792376084 0.1242806493745657 0.9010930680708058 1.0 1.0 15 P28482,P63000,Q02750,P43246,Q07812,P11233 6 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.3836552748885607 0.1162438966109894 0.9074592480753358 1.0 1.0 3 P28482,P27361 2 |
| Methionine de novo and salvage pathway 0.2972329663790575 0.115080808273172 0.908381071607398 1.0 1.0 7 Q9NZL9,Q99707,P23526,P31153,P19623,Q13126 6 |
| Heart development 0.3513752261709243 0.1036722595453519 0.91742944167818 1.0 1.0 3 P28482 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.3440285204991168 0.1035413906717356 0.9175333010008352 1.0 1.0 2 Q04206 1 |
| Purinergic signaling 0.2760384622278641 0.1035248328713607 0.9175464415973288 1.0 1.0 5 P63096 1 |
| Nrf2are regulation 0.289755807027987 0.102720075870669 0.9181851396870732 1.0 1.0 10 P09601,Q9UPY5,Q13155,P48506,P49841,Q96HS1,P48507,P17252,Q13618 9 |
| Insulin signaling in adipocytes diabetic condition 0.3453194650817256 0.1019723245243779 0.918778642379118 1.0 1.0 3 P62753,O60343 2 |
| Insulin signaling in adipocytes normal condition 0.3453194650817256 0.1019723245243779 0.918778642379118 1.0 1.0 3 P62753,O60343 2 |
| Transcription cofactors ski and skil protein partners 0.2655367231638494 0.0965033937341495 0.9231207786982418 1.0 1.0 5 O14744,P51608,Q13188,Q13547 4 |
| Interleukin1 il1 structural pathway 0.2826410831079154 0.0849259289422924 0.9323202779352782 1.0 1.0 9 P28482,Q02750,P06730,P36507,Q04206 5 |
| Osteoblast differentiation and related diseases 0.2719100335829179 0.068170895574453 0.9456495950251728 1.0 1.0 10 O00459 1 |
| Photodynamic therapyinduced unfolded protein response 0.2711816409410923 0.0668956877356928 0.9466647460387584 1.0 1.0 10 O43776,P23381,P05198 3 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.2607146903398931 0.0594511777888541 0.952592751130462 1.0 1.0 8 P28482,Q8WUM4,P27361,O14964 4 |
| P38 mapk signaling pathway 0.257378841666565 0.055732280259381 0.9555550835295056 1.0 1.0 8 P62993,P04792 2 |
| Il3 signaling pathway 0.2733341713253622 0.0515317423968527 0.9589018086695216 1.0 1.0 14 P28482,Q02750,Q06124,P62993,P27348,O00459,P27361 7 |
| Vegfavegfr2 signaling pathway 0.3474892942479209 0.0512369918994582 0.9591366752696836 1.0 1.0 179 Q96SB4,O14773,Q96KB5,P30825,Q9NYL9,P15311,O00560,Q16527,P47756,P07737,Q16512,P62993,P55209,P19338,Q15650,P05556,P23528,P35579,P04792,O00299,Q14157,Q12800,O14964,O15355,P06753,Q96B36,P54920,Q01844,Q9H299,P63000,Q02750,Q9NZB2,P07900,P06730,O00459,Q13177,Q96CT7,P42566,Q96J02,P55036,P06756,P05198,P28482,Q9Y678,O43852,O15372,P09429,P00491,O75347,P46108,P35613,P29317,Q01105,Q8WU90 54 |
| Endoderm differentiation 0.2944180691929842 0.048172791067981 0.9615785345865616 1.0 1.0 30 P05067 1 |
| Myometrial relaxation and contraction pathways 0.2816514682975197 0.0476439552738795 0.962000000542422 1.0 1.0 17 P62258,Q05682,P63104,Q9UBI6,P27348,P10644 6 |
| Measles virus infection 0.2918634977514483 0.0433328606744399 0.9654361967850889 1.0 1.0 26 P19525,P67870,Q9Y6K9,O00459,P05198 5 |
|
|
